Research Library · Category

Growth Hormone & Endocrine Peptides

Endocrine research compounds in this category are studied for their interaction with the growth-hormone axis — as growth-hormone-releasing hormone (GHRH) analogs, ghrelin-receptor secretagogues, and related signaling factors evaluated in laboratory models.

9 compoundsPathway the growth-hormone axis via GHRH and ghrelin-receptor signalingResearch Use Only

01Compounds in This Category

Endocrine3,367.8 g/mol

CJC-1295

A growth-hormone-releasing hormone analog studied for pulsatile GH secretion.

View compound →
Endocrine711.85 g/mol

Ipamorelin

A selective ghrelin-receptor agonist studied for clean growth-hormone secretagogue activity.

View compound →
Endocrine3,357.9 g/mol

Sermorelin

A GHRH(1-29) analog studied for pituitary growth-hormone stimulation.

View compound →
Endocrine5,135.9 g/mol

Tesamorelin

A stabilized GHRH(1-44) analog studied for growth-hormone-axis and lipid metabolism.

View compound →
Endocrine887.04 g/mol

Hexarelin

A growth-hormone-releasing hexapeptide studied for GHS-R and CD36 signaling.

View compound →
Endocrine817.97 g/mol

GHRP-2

A growth-hormone-releasing hexapeptide studied for GHS-R agonism.

View compound →
Endocrine9,117.7 g/mol

IGF-1 LR3

A long-acting IGF-1 analog studied for IGF-1R signaling and cell proliferation.

View compound →
Endocrine— (PEGylated)

PEG-MGF

A PEGylated IGF-1 splice variant studied for satellite-cell proliferation pathways.

View compound →
Endocrine3,647.2 g/mol

CJC-1295 DAC

A GHRH analog with an albumin-binding Drug Affinity Complex for extended half-life.

View compound →

02How These Are Studied

Compounds in this category are grouped by their association with the growth-hormone axis via GHRH and ghrelin-receptor signaling. Classification reflects the primary research pathway each compound is studied within; many are also evaluated across adjacent mechanisms. Selection for any research model depends on the specific question, system, and endpoints under study.

All are supplied strictly for laboratory research and are not for human or veterinary use.

03FAQ

What are growth hormone & endocrine peptides?

Endocrine research compounds in this category are studied for their interaction with the growth-hormone axis — as growth-hormone-releasing hormone (GHRH) analogs, ghrelin-receptor secretagogues, and related signaling factors evaluated in laboratory models.

Which compounds are in the endocrine category at Ethos Bio?

This category includes CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, Hexarelin, GHRP-2, IGF-1 LR3, PEG-MGF, CJC-1295 DAC. Each is analyzed by an independent third-party laboratory (MZ Biolabs) on a five-point panel with a batch-specific Certificate of Analysis.

How are these compounds tested?

Every lot is tested by MZ Biolabs (Arizona) on a five-point panel — HPLC purity, mass-spec identity, endotoxin, heavy metals, and sterility — with a batch-specific Certificate of Analysis provided per order.

See how every lot is tested → · Compare compounds →